bioRxiv Science⌕ Search

bioRxiv · 10.1101/2020.01.10.901470

Serological evidence of Rift Valley fever infection and risk factors among one humped camels (Camelus dromedarius) in Northern Nigeria.

Abstract

BackgroundRift Valley fever (RVF) is a zoonotic disease that has become emerging and re-emerging in some regions of the world, infecting livestock and humans. One-humped camels are important economic livestock species in Africa used for traction, transportation, and food. Regional and international trade has continued to increase the risk of this disease, spreading widely and causing severe economic and public health catastrophes in affected regions. In spite of these risks, there is a dearth of information about the status of RVF in camels in Nigeria. This study was carried out to determine the prevalence of the RVF virus in one-humped camels in Nigeria and identify the risk factors associated with the disease. MethodsA cross-sectional study with simple random sampling was carried out in seven local government areas of Jigawa and Katsina States. The sera from camels were tested for anti-RVFV IgG. Camel owners were administered a structured questionnaire to ascertain their knowledge, attitude, and practice. ResultsAn overall prevalence of 19.9% (95% CI; 17.07-22.90) was recorded. Based on age groups, the highest prevalence of 20.9% (95% CI; 17.00-25.31) was obtained among older camels (6-10 years), while female camels recorded a high prevalence of 20.4% (95%CI; 15.71-25.80). Sule Tankar-kar recorded the highest prevalence with 33% (95%CI; 1.31-4.72, p= 0.007) and OR 2.47 in Jigawa State while Maiadua had 24.7% (95%CI; 0.97-2.73, p=0.030) with OR 1.62 in Katsina State respectively. From the risk map, local government areas bordering Niger Republic were at a high risk of RVF. Only high rainfall was not significantly linked with RVF occurrence among nomadic camel pastoralists (95%CI 0.93-5.20; p=0.070). ConclusionThere is a need for the country to have quarantine units across borders for screening animals coming from neighbouring countries for transboundary infectious diseases such as RVF. Author SummaryRift Valley fever is a viral haemorrhagic fever that affects animals and humans with high mortality. Recently there has been increased demand in camel meat and products for food and therapeutic purposes. Climate change, coupled with insecurity in the Sahel, has had a significant impact on transhumance activities where camels and their owners move to different countries in search of pasture for their animals. Though Nigeria has not reported an outbreak of Rift Valley fever despite serological evidence in various animal species, there is a need to assess RVF in camels, which is a critical animal species, involved in transhumance with the potential of introducing transboundary diseases into new areas. The study assessed the presence of antibodies in camels, identified risk factors associated with the disease in camels and areas at risk for the disease. Our study found a seroprevalence of 19.9% in camels in two northern states of Nigeria, which shares a boundary with the Niger Republic that recently reported an outbreak. Our findings suggest that areas in proximity to Niger Republic are at a high risk to the disease and camels belonging to transhumance pastoralists are highly likely to contract Rift Valley fever since they are exposed to various ecological and environmental factors that precipitate the disease.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Adamu, A. M., Yila, S. A., Allam, L., Sackey, A., Alhaji, N. B., Garba, B. S., Mambula, S. M., Nafarnda, W. D., Idoko, I. S., Balogun, E. O., Owolodun, O. A., Dzikwi, A. A.. 2020-01-10. Serological evidence of Rift Valley fever infection and risk factors among one humped camels (Camelus dromedarius) in Northern Nigeria.. https://doi.org/10.1101/2020.01.10.901470

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Reverse Transcription Loop-Mediated Isothermal Amplification Combined with Lateral Flow Assay (RT-LAMP-LFA) for Rapid Detection of the 2026 Bundibugyo Virus (BDBV) Outbreak Strain

Making accurate diagnosis is a critical first step in patient management and control for emerging and re-emerging disease outbreaks. Bundibugyo virus (BDBV) is a filovirus that causes Ebola disease, and the 2026 outbreak highlights the need for rapid diagnostic approaches that can be deployed in settings with limited laboratory infrastructure. Here, we developed a reverse transcription loop-mediated isothermal amplification-lateral flow assay (RT-LAMP-LFA) for rapid detection of the 2026 BDBV outbreak strain. LAMP primers were designed based on the genome sequence of the 2026 outbreak strain, and the conservation of the primer binding sites among all available 2026 outbreak genomes was confirmed in silico. LAMP primers were evaluated for analytical specificity and sensitivity using in vitro-transcribed RNA (ivtRNA) from BDBV and other filoviruses, as well as RNA derived from arboviruses and mammalian cells. Amplification products were detected using a Chromatography-Printed Array Strip (C-PAS) lateral flow platform. The newly designed primers specifically detected the presence of BDBV RNA without nonspecific amplification of the other viral or cellular RNA samples tested. Consistent amplification was observed down to 103 copies per reaction. In addition, BDBV viral RNA was successfully amplified, and the amplification products were detected using C-PAS, with the total workflow being completed within 25 min. These findings demonstrate the analytical specificity and sensitivity of the developed RT-LAMP-LFA assay and its compatibility with rapid visual lateral flow detection, supporting its potential application as a point-of-care approach for BDBV detection.

microbiology↗

Divergent methane production and microbial community responses to carbon enrichment in freshwater wetland sediments

Methane (CH4) accumulation in wetland sediments reflects interactions among organic matter, sediment chemistry, and microbial communities. We combined depth-resolved field characterization across four wetland habitats in northern Israel with complementary incubations to examine methane accumulation and responses to labile-carbon enrichment. Sediment cores were characterized using Rock-Eval analysis, porewater chemistry, oxygen profiling at three sites, and mcrA amplicon sequencing. High CH4 concentrations occurred under contrasting conditions: Ein Nimfit (EN) contained approximately 12% total organic carbon and reached 2.1 mM CH4, whereas Ein Afek site EA2 contained approximately 5% carbon and accumulated 0.7-1.7 mM CH4. Both showed sulfate depletion, but EN exhibited pronounced sulfide accumulation, whereas EA2 showed greater dissolved iron and nutrient enrichment. Their classified methanogenic assemblages also differed. EA1 remained methane poor despite increasing carbon content with depth, while EA3 combined low carbon content and CH4 accumulation with detectable methanogens and lower methanogenic diversity. In a 36-day bottle experiments using sediments from two of the four wetland habitats, sucrose-amended EA3 exhibited a transient maximum of 18.8 mmol collected CH4 kg-1 wet sediment during Days 22-29, whereas EN reached its highest collected amount during Days 29-36. Methane proportions increased before the large output increase in EA3 but remained comparatively stable and high in EN. Soluble chemical oxygen demand trajectories and microbial community changes also differed. These findings identify distinct biogeochemical settings supporting methane accumulation and demonstrate methanogenic potential in low-CH4 sediment, emphasizing the complementary information provided by field profiles, microbial characterization, and exploratory enrichment experiments.

microbiology↗

The absence of microbiome in germ-free mice exacerbates the pathogenicity of mouse-adapted SARS-CoV-2 MA10

Germ-free mice, which are devoid of microbiota, provide a powerful system to define the contribution of the microbiome to host responses during infection. Severe COVID-19 outcomes are associated with multiple comorbidities that are themselves characterized by microbiome dysbiosis; however, the causal role of the microbiota in SARS-CoV-2 pathogenesis remains poorly understood. Here, we use germ-free mouse models to evaluate the impact of the microbiome on disease severity following infection with mouse-adapted SARS-CoV-2 MA10. Comparison with conventionally housed mice revealed that the absence of the microbiome markedly exacerbates SARS-CoV-2-induced disease in both C57BL/6 and Swiss Webster backgrounds. Germ-free mice exhibited greater weight loss, impaired lung function, worsened pulmonary pathology, and pronounced alterations in circulating cytokine and chemokine profiles compared with conventional controls. These findings show that resident microbiota limit SARS-CoV-2 pathogenicity and establish germ-free COVID-19 models as a powerful platform to identify protective microbial taxa and microbiota-based interventions to reduce severe disease.

microbiology↗